News

A collaborative research team has synthesized a molecule that could be used as an alternative to the antibodies used in immunotherapy treatment for cancer. The study is published in the Journal for ImmunoTherapy of Cancer.

In 2020, more than 1.5 million people died of tuberculosis (TB). Now, researchers have developed a TB drug that showed potential with just one injection that lasts at least four months, improving on current treatment which requires daily medication.

Scientists at the University of California, Berkeley, have created a new COVID-19 therapeutic that could one day make treating SARS-CoV-2 infections as easy as using a nasal spray for allergies.

The immune boosting benefits of a tuberculosis vaccine can be seen in infants more than one year after vaccination, according to a new study.

A new method of producing antibiotics by modifying existing natural products by adding fluorine has been developed, opening doors for the discovery of new therapeutics.

Researchers have now developed a special hydrogel that vastly improves the shelf life of vaccines, even without refrigeration.

Scientists have established the presence of various species of the Arcobacter genus in a range of routinely consumed foodstuffs.

New insights into the replication mechanisms of coronaviruses, including SARS-CoV-2 and MERS-CoV-2, have been revealed by researchers at the University of Hong Kong.

Research shows that microbes on floating plastic particles can be transported over long horizontal distances but don't reach deep sea eco-systems.

A new study from researchers at the University of Sydney has explored how 10 different diets – including those high in protein, carbohydrates and fat – affect the gut microbiota in mice.